Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Dextenza® (dexamethasone) – Expanded indication
June 21, 2019 - Ocular Therapeutix announced the FDA approval of Dextenza (dexamethasone), for the treatment of ocular inflammation and pain following ophthalmic surgery.
